Pages
Derbyshire Health and Care System Continues to Declare Critical Incident
https://dchs.nhs.uk/news/derbyshire-health-and-care-system-continues-declare-critical-incident
My Download - 15 November 2021
Weekly all staff e-newsletter
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/my-download-15-november-2021
Health Psychology FAQs
Frequently Asked Questions about health psychology for the people of Derby and Derbyshire
Op COURAGE: The Veterans Mental Health and Wellbeing Service
https://dchs.nhs.uk/news/op-courage-veterans-mental-health-and-wellbeing-service
Bakewell’s new NHS health hub opening date confirmed for 23 September 2024
https://dchs.nhs.uk/news/bakewells-new-nhs-health-hub-opening-date-confirmed-23-september-2024
Files
L302 - My Respiratory Action Plan
L302 - My Respiratory Action Plan
PAT Procedure
PAT Procedure
DCHS Tissue Viability Non-Concordance guidelines and Pathway (G309)
DCHS Tissue Viability Non-Concordance guidelines and Pathway
ICS Catheter Clinic Guidance (G324)
ICS Catheter Clinic Guidance
Policy template FINAL (DCHS Policy Development Framework)
Policy template FINAL (DCHS Policy Development Framework)
Disclosure Ref 2024135 - No. of Datix Incidents Involving Patient Misidentification.pdf
FOI Disclosure Ref 2024135 regarding number of Datix Incidents Involving Patient Misidentification
Disclosure Ref 2024128 - Social Media Platforms.pdf
FOI Disclosure Ref 2024128 - Social Media Platforms
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates.pdf
Disclosure Ref 2024134 - Trust Policy for Scope of Nursing Associates
INR Testing procedure within Derbyshire Community Health Services by Podiatry Surgery at Ilkeston and Buxton Hospitals (S128)
Only podiatric surgery with the relevant equipment, training and framework in place will be able to utilise this procedure. This clinical procedure will support clinical staff in practice to include arrangements with regards the procedure of the taking of the INR test, quality assurance /quality control, Control of Substances Hazardous to Health (COSHH) assessment, Infection control measures, and any relevant Health and Safety issues. In line with recommendations within the Medicines and Healthcare Products Regulatory Agency (MHRA) Device Bulletin “Management and use of In Vitro Diagnostic (IVD) Point of Care Test Devices DB 2010(02) February 2010
A1 - Observational Audit - protected meal times (G50)
Observational Audit - protected meal times